NUOX
NUOX clinical trials: NuvOx Therapeutics, Inc.
Every trial on ClinicalTrials.gov where NuvOx Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 7
- As lead sponsor
- 2
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
NUOX on the catalyst calendar · NUOX registry changes
- Primary completion Jun 30, 2027Sponsor estimatePhase 2NCT03862430A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBMNuvOx LLC · Glioblastoma MultiformeActive, not recruitingNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT07748299NuvOx Expanded AccessNuvOx LLC · GlioblastomaAvailableNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateNo phase registeredNCT07417774Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen TherapeuticNuvOx LLC · Glioblastoma (GBM)Enrolling by invitationNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1NCT06658535A Dose Escalation Study of NanO2 in Patients With Mild Respiratory DistressNuvOx LLC · Mild Respiratory DistressRecruitingNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2025Sponsor estimatePhase 2/Phase 3NCT05389748NanO2 for Large Vessel Occlusion StrokeNuvOx LLC · Ischemic StrokeUnknown statusNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 9, 2018ActualPhase 1NCT02963376A Phase Ib/II in Patients With Acute Ischemic StrokeNuvOx LLC · Ischemic StrokeCompletedNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2017ActualPhase 1NCT02189109The Effects of NVX-108 as a Radiation Sensitizer in GlioblastomaNuvOx LLC · Glioblastoma MultiformeCompletedNUOXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2026Sponsor estimatePhase 2NCT06821347NanO2 in Large VessEL Occlusion Stroke (NOVEL)NHS Greater Glasgow and Clyde · Stroke AcuteNot yet recruitingNUOXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2018Sponsor estimatePhase 1NCT03013426A Phase Ib Study of NVX-508 in Sickle Cell DiseaseAmma Owusu-Ansah, MD · Sickle Cell DiseaseWithdrawnNUOXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner